Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Plastic and Reconstructive Surgery|August 4, 2010
Utility scores for facial disfigurement requiring facial transplantation [outcomes article]Hani H Sinno, Stephanie Thibaudeau, Anil Duggal, et al.Journal of Reconstructive Microsurgery|August 24, 2011
Surgical aspects of donor hand recovery for transplantationRodrigo N Banegas, Rodrigo Moreno, Anil Duggal, et al.Canadian Journal of Surgery. Journal Canadien De Chirurgie|September 26, 2008
Pathological reporting of colorectal cancer specimens: a retrospective survey in an academic Canadian pathology departmentNancy G Chan, Anil Duggal, Michele M Weir, et al.Clinical Pharmacology and Therapeutics|February 18, 2024
Pharmacokinetics, Pharmacodynamics, and Safety of Edoxaban in Pediatric Subjects: A Phase I Single-Dose StudyPeng Zou, Hamim Zahir, Anil Duggal, et al.Annals of Plastic Surgery|March 13, 2010
International interdisciplinary rhytidectomy surveyD Heath Stacey, Jeremy P Warner, Anil Duggal, et al.Clinical Pharmacology in Drug Development|December 8, 2021
Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/minOphelia Yin, Tarundeep Kakkar, Anil Duggal, et al.American Heart Journal|October 24, 2008
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) TrialRobert M Califf, Mitradev Boolell, Steven M Haffner, et al.Haematologica|October 19, 2023
Impact of mild thrombocytopenia on bleeding and recurrent thrombosis in cancerRushad Patell, Charles Hsu, Minggao Shi, et al.Cancer|August 28, 2003
A Phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with metastatic breast carcinomaFrancisco J Esteva, Edgardo Rivera, Massimo Cristofanilli, et al.Clinical Pharmacokinetics|May 18, 2017
An Open-Label Crossover Study of the Pharmacokinetics of the 60-mg Edoxaban Tablet Crushed and Administered Either by a Nasogastric Tube or in Apple Puree in Healthy AdultsKenneth Duchin, Anil Duggal, George J Atiee, et al.Pageof 3